Quest Diagnostics reported Q1 2026 revenue of $2.90 billion (+9.2% year-over-year), reported diluted EPS of $2.24 (+15.5%), and raised full-year guidance. The 10-Q filed April 22, 2026 decomposes the growth bluntly: total volume +10.9% year-over-year, revenue per requisition -1.30%, and roughly 7 percentage points of the 10.8% organic volume growth came from two specific contract relationships — Fresenius Medical Care end-stage renal disease and the Corewell Health Collaborative Lab Solutions. Excluding those two relationships, organic volume grew only 3.8% and the underlying clinical revenue per requisition rose approximately 2.5%. The segment footnote shows DIS operating margin expanded only 15 basis points while consolidated operating margin expanded 73 basis points, a gap created by a $11 million reduction in general corporate activities expense. Equity-method investee earnings collapsed from $18 million to $4 million — a silent ~$0.10 per share drag not addressed in management's adjusted-EPS bridge.
United Rentals reported Q1 2026 revenue of $3.985 billion (+7.2% year-over-year), adjusted EPS of $9.71, and raised full-year guidance — and the 10-Q filed April 22, 2026 lets a retail reader see the margin picture management's headline compression language hides. Net margin printed 13.32%, down 60 basis points year-over-year. Back out the $29 million after-tax benefit from the 2025 H&E merger break-up (which will not recur) and the new $45 million Q1 2026 restructuring charge (which did not exist last year), and underlying net margin is about +20 basis points year-over-year. The segment split shows the real operating story: General rentals gross margin +150 bps to 33.8% while Specialty gross margin -170 bps to 41.4% on a mix-driven drag that is not in the press release's one-sentence treatment.
CSX Corp.'s Q1 2026 10-Q, filed April 22, 2026, shows operating margin hitting 36.0% — a 558 basis-point year-over-year expansion and the best Q1 in the eight-quarter window MetricDuck tracks. The 10-Q rail-segment footnote discloses a $44 million gain on property disposition embedded inside the $153 million expense decline — a line the 8-K press release and the earnings-call narrative did not itemize. Backing it out, 'core' margin expansion is closer to 430bps and underlying operating-income growth is about +16%, not the headline +20%. Freight receivables also jumped 15.4% quarter-over-quarter against flat sequential revenue, creating a $130 million working-capital drag that softens the cash-earnings story.
Intuitive Surgical's Q1 FY2026 10-Q, filed April 22, 2026, discloses an operating margin of 30.9% — the highest Q1 on record — along with a $528 million European distributor acquisition that closed March 1 and a $339 million one-time tax benefit from accelerated research and development deductions. The filing reframes the outperformance narrative that the 8-K earnings release and prior earnings call established, because roughly one month of acquired distribution revenue and a §174 tax-timing tailwind are inside the headline numbers. Operating leverage is real — but so is the footnote-level tariff language ISRG placed in accounting policies rather than in Item 1A risk factors.
NIKE reported flat Q3 FY2026 revenues of $11.28B and beat EPS estimates at $0.35, but the 10-Q tells a different story. Operating cash flow collapsed 76% year-over-year to $430M, dividends of $609M exceeded net income of $520M by 17%, and share repurchases were zero for the quarter. The gap between the EPS story on the call and the cash reality in the filing is the defining feature of this quarter.